Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredShares IssuedShares OutstandingShares Outstanding
Ratios

Fulcrum Therapeutics (FULC) Receivables - Accured (2019 - 2026)

Fulcrum Therapeutics (FULC) has disclosed Receivables - Accured for 7 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Receivables - Accured fell 14.13% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, down 14.13% year-over-year, with the annual reading at $1.1 million for FY2025, 14.13% down from the prior year.
  • Receivables - Accured for Q4 2025 was $1.1 million at Fulcrum Therapeutics, up from $934000.0 in the prior quarter.
  • The five-year high for Receivables - Accured was $1.7 million in Q4 2023, with the low at $102000.0 in Q1 2021.
  • Average Receivables - Accured over 5 years is $927050.0, with a median of $1.1 million recorded in 2024.
  • Peak annual rise in Receivables - Accured hit 449.3% in 2021, while the deepest fall reached 42.37% in 2021.
  • Over 5 years, Receivables - Accured stood at $473000.0 in 2021, then skyrocketed by 80.13% to $852000.0 in 2022, then soared by 100.94% to $1.7 million in 2023, then dropped by 27.22% to $1.2 million in 2024, then dropped by 14.13% to $1.1 million in 2025.
  • According to Business Quant data, Receivables - Accured over the past three periods came in at $1.1 million, $934000.0, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.